Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
This article breaks down the key drivers behind global stock indices, including economic data, central bank policy, and market sentiment.
20,453 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Lionsgate delivered stronger-than-expected results, and its stock jumped. This article breaks down the key factors be...
A Perdoceo director recently exercised 9,308 options and sold shares, triggering questions for investors. This guide ...
Micron Technology surged to a fresh all-time high after a blockbuster earnings report and strong AI-driven demand. Th...
SpaceX is a private company, and headlines about members congress recently bought stock can be misleading. This guide...
Long-term compound growth in tech requires durable moats and disciplined capital allocation. Here are two powerhouse ...
A Friday announce could insert Marvell into the S&P 500 after a dramatic stock surge. The company's market cap dwarfs...
A top move in growth investing is drawing attention: cathie wood's invest bought SpaceX stock. This article breaks do...
Big tech is pouring hundreds of billions into AI infrastructure. This creates opportunities for selective stocks. Lea...
Anthropic's IPO signals more than one company going public. It underscores a rising demand for AI compute, potentiall...
A director’s stock sale can spark worry, but not every insider move is a warning. This guide shows how to assess trad...
When a top executive sells stock, the market takes notice. This deeper look at Bristow Group's just sold helps you se...